Better Therapeutics has become the latest company in the digital health sector to announce big job cuts, saying it needs to conserve cash as it waits for FDA approval of i
Illumina has bitten back against the attempt by billionaire activist investor Carl Icahn to introduce three members to its board, saying that they lack “experience in and
Pear Therapeutics already has three FDA-approved prescription digital therapeutics (DTx) on the market – but it seems that isn’t enough to ensure a stable financial positi
Billionaire activist investor and ‘corporate raider’ Carl Icahn is lining up a proxy battle at Illumina in the wake of its troubled $7.1 billion takeover of blood-based ca
The shutdown on Friday of Silicon Valley Bank (SVB) – a major backer of biotech companies – will not leave any US customers out of pocket, according to the federal governm
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough